NWPF

News ArchivesRead News

A new gig

Thursday October 19, 2006

Michael J. Fox Foundation Launches Parkinson’s Genetics Database PDGene

10/12/2006(U.S. News Wire) - The Michael J. Fox Foundation announced that it has collaborated with Dr. Lars Bertram of Massachusetts General Hospital (MGH) and with The Alzheimer Research Forum (AlzForum) to create PDGene ( http://www.pdgene.org ), an online inventory of studies on genes implicated in Parkinson’s disease.

"Given the rapid pace of genetic discovery and the previous lack of a centralized information source for these discoveries, the development of PDGene is an essential step in raising awareness to translate genetic discoveries into treatments," said Deborah W. Brooks, the Foundation’s president and CEO. "We are confident that PDGene will help keep the field informed and unify future steps toward improved therapies that will significantly impact patients’ lives."

The first tool of its kind for Parkinson’s, PDGene is a nod to the field’s need for a more refined understanding of possible genetic contributions to Parkinson’s disease risk. To date, only a handful of genes have been identified that are strongly linked to rare hereditary forms of Parkinson’s disease. For the vast majority of Parkinson’s cases, however, recent work indicates that there is no single shared genetic ’smoking gun.’ More likely, multiple gene variants, as well as environmental factors, may interact to affect an individual’s risk of developing the disease. The combination of factors may also differ from group to group, further complicating attempts to understand the disease and making it difficult to replicate genetic findings from one study to the next.

PDGene is a centralized and regularly updated web portal for scientists, who will now find in one place information about any gene that previous research has shown may play a role in Parkinson’s. Information available in PDGene includes a list of all published papers that looked for a link between a gene and PD (whether supportive or not); basic information about each study; and an overall determination of how strong the evidence is for a gene’s link to PD, based on pooled results from the published studies. Scientists will also be able to submit comments about each study. Content decisions will be made by Dr. Bertram’s team at MGH with oversight from a Scientific Advisory Board consisting of PD researchers and geneticists, including representation from The Michael J. Fox Foundation. To ensure the database’s objectivity, only those studies published in peer- reviewed journals will be considered for inclusion in the database. Papers also must be available in English.

"I am pleased to be working alongside The Michael J. Fox Foundation and The Alzheimer Research Forum to develop such an important tool for the Parkinson’s community," said Dr. Bertram, assistant professor of neurology at Harvard Medical School. "The role of genetics in Parkinson’s is complex and there is a crucial need for shared tools and resources such as PDGene."

PDGene models an existing database called AlzGene, also created by Dr. Bertram and his group in collaboration with The Alzheimer Research Forum. Alzforum is dedicated to understanding Alzheimer’s by reporting on the latest scientific findings, from basic research to clinical trials, and maintaining public databases of essential research data.

"We are delighted to work with The Michael J. Fox Foundation and Dr. Bertram on PDGene," said June Kinoshita, AlzForum’s executive editor.

"We hope that our collaboration on this project will help foster greater interaction among researchers who are studying Parkinson’s, as it has done for those researchers studying Alzheimer’s."

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement